Inventor · disambiguated record
Tsann-Long Su
Also filed as: SU TSANN-LONG
14 granted patents·4 pending applications·52 citations·filing 1989–2020
89Inventor score
Files withACADEMIA SINICA6SU TSANN-LONG6SLOAN KETTERING INST CANCER4LEE TE-CHANG1NAT HEALTH RESEARCH INST1
Top patents by PatentIndex Score
18 records- 0178US9662324B2Methods and compositions for treating β-thalassemia and sickle cell diseaseACADEMIA SINICA·Filed 2014·Granted May 30, 2017·3 cites·16 claims
- 0278US8222297B2Aniline or phenol mustards linked to DNA-affinic molecules or water-soluble aromatic rings and their use as cancer therapeutic agentsSU TSANN-LONG·Filed 2008·Granted Jul 17, 2012·4 cites·4 claims
- 0376US5112869ASubstituted 1-phenylnaphthalenesSLOAN KETTERING INST CANCER·Filed 1989·Granted May 12, 1992·15 cites·13 claims
- 0464US5354864A3-(9-acridinylamino)-5-hydroxymethylaniline derivatives as anticancer agentsSLOAN KETTERING INST CANCER·Filed 1992·Granted Oct 11, 1994·11 cites·3 claims
- 0562US5476952AAntitumor cyclopentnaphthoquinone and cyclopentanthraquinone derivativesSLOAN KETTERING INST CANCER·Filed 1993·Granted Dec 19, 1995·10 cites·3 claims
- 0658US6821983B25-(9-acridinylamino)-toluidine compoundsACADEMIA SINICA·Filed 2003·Granted Nov 23, 2004·1 cites·35 claims
- 0755US10548861B2Use of ureidomustine (BO-1055) in cancer treatmentACADEMIA SINICA·Filed 2016·Granted Feb 4, 2020·0 cites·5 claims
- 0855US8410130B2Synthesis of 8H-3A-aza-cyclopenta [A ]indenes and 5,10-dihydropyrrolo[1,2-B]isoquinolines derivatives and their use as antitumor therapeutic agentsSU TSANN-LONG·Filed 2008·Granted Apr 2, 2013·0 cites·21 claims
- 0955US2017290820A1Methods and compositions for treating beta-thalassemia and sickle cell diseaseACADEMIA SINICA·Filed 2017·Application pending·0 cites
- 1051US2020246284A1Use of Ureidomustine (BO-1055) in Cancer TreatmentACADEMIA SINICA·Filed 2020·Application pending·0 cites
- 1149US9193687B2Phenyl N-mustard linked to DNA-affinic molecules or water-soluble aryl rings, method and their use as cancer therapeutic agentsSU TSANN-LONG·Filed 2012·Granted Nov 24, 2015·0 cites·13 claims
- 1248US5939428AAlkyl N- 3-(acridin-9-yl)amino-5-hydroxymethyl! phenylcarbamatesNAT HEALTH RESEARCH INST·Filed 1998·Granted Aug 17, 1999·6 cites·6 claims
- 1345US8772284B2Method of treating cancer using combination of a bifunctional alkylating agent and DNA repair inhibitorsLEE TE-CHANG·Filed 2010·Granted Jul 8, 2014·0 cites·14 claims
- 1445US8703951B2Synthesis of 4H-benzo[D]pyrrolo[1,2-A]thiazoles and indolizino[6,7-b]indole derivatives and their use as antitumor therapeutic agentsSU TSANN-LONG·Filed 2012·Granted Apr 22, 2014·0 cites·8 claims
- 1544US2008176889A19-anilinoacridine alkylating agentsSU TSANN-LONG·Filed 2004·Application pending·0 cites
- 1642US5296602AMultisubstituted 1-hydroxy-9-acridones with anticancer activitySLOAN KETTERING INST CANCER·Filed 1991·Granted Mar 22, 1994·2 cites·17 claims
- 1740US11066412B2Substituted pyrrolo[2,1-a]phthalazines and benzo[g]pyrrolo[2,1-a]phthalazines for the treatment of cancerACADEMIA SINICA·Filed 2018·Granted Jul 20, 2021·0 cites·25 claims
- 1840US2019247371A1Methods for treating small cell lung cancers by using pharmaceutical compositions or combinations comprising indolizino[6,7-b]indole derivativesSU TSANN LONG·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tsann-Long Su files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →